Insider Buy/Sell Details for the Biotechnology Industry — April 2026
Ratio0.0:1
Daily Buy & Sell Volume
Transactions (362)
Kymera Therapeutics, Inc. (KYMR)
Chadwick Jeremy G — Chief Operating Officer
Shares
13,540
Price
$85.41
Total Value
$1.16M
Shares Held After
62,302
% of Holdings
17.9%
Kymera Therapeutics, Inc. (KYMR)
Ridloff Elena — Director
Shares
1,200
Price
$86.05
Total Value
$103.26K
Shares Held After
0
% of Holdings
100.0%
Kymera Therapeutics, Inc. (KYMR)
Ridloff Elena — Director
Shares
3,400
Price
$85.19
Total Value
$289.66K
Shares Held After
1,200
% of Holdings
73.9%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
4,278
Price
$4.97
Total Value
$21.26K
Shares Held After
426,816
% of Holdings
1.0%
CYTOKINETICS INC (CYTK)
Blum Robert I — Director
Shares
7,500
Price
$66.63
Total Value
$499.72K
Shares Held After
422,830
% of Holdings
1.7%
Altimmune, Inc. (ALT)
Durso Jerome Benedict — Director
Shares
15,000
Price
$3.14
Total Value
$47.10K
Shares Held After
47,500
% of Holdings
31.6%
Altimmune, Inc. (ALT)
WEAVER GREGORY L — Chief Financial Officer
Shares
10,000
Price
$3.15
Total Value
$31.50K
Shares Held After
38,078
% of Holdings
26.3%
Showing 151–200 of 362 transactions (page 4 of 8)